Diagnostic value of miR-101 levels in blood and urine of patients with hypertensive disorder complicating pregnancy

References

• Mersha AG, Abegaz TM, Seid MA. Maternal and perinatal outcomes of hypertensive disorders of pregnancy in Ethiopia: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19(1):458. doi:10.1186/s12884-019-2617-8.
   PubMed Web of Science ®Google Scholar
• Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019;105(16):1273–78. doi:10.1136/heartjnl-2018-313453.
   PubMed Web of Science ®Google Scholar
• Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213–20. doi:10.1038/hr.2016.126.
   PubMed Web of Science ®Google Scholar
• Shibuya M, Matsui H, Sasagawa T, Nagamatsu T. A simple detection method for the serum sFLT1 protein in preeclampsia. Sci Rep. 2021;11(1):20613. doi:10.1038/s41598-021-00152-6.
   PubMed Web of Science ®Google Scholar
• Correa PJ, Palmeiro Y, Soto MJ, Ugarte C, Illanes SE. Etiopathogenesis, prediction, and prevention of preeclampsia. Hypertens Pregnancy. 2016;35(3):280–94. doi:10.1080/10641955.2016.1181180.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wan P, Ng K, Singh K, Cheng TH, Velickovic I, Dalloul M, Wlody D . Preeclampsia among African American pregnant women: an update on prevalence, complications, etiology, and biomarkers. Obstet Gynecol Surv. 2020;75(2):111–20. doi:10.1097/OGX.0000000000000747.
   PubMed Web of Science ®Google Scholar
• Li L, Ling B, Mei J, Wang Y, Zhang J, Zhao X . Expression and significance of serum soluble fms-like tyrosine kinase 1 (sFlt-1), CXC chemokine ligand 16 (CXCL16), and lipocalin 2 (LCN-2) in pregnant women with preeclampsia. Ann Palliat Med. 2021;10(7):7866–71. doi:10.21037/apm-21-1553.
   PubMed Web of Science ®Google Scholar
• Nguyen TH, Bui TC, Vo TM, Luu LT, Nguyen TD. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam. Pregnancy Hypertens. 2018;14:37–42.
   PubMed Web of Science ®Google Scholar
• Sahay AS, Jadhav AT, Sundrani DP, Wagh GN, Mehendale SS, Chavan-Gautam P, Joshi SR . VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae. Mol Cell Biochem. 2018;438(1–2):141–52. doi:10.1007/s11010-017-3121-y.
   PubMed Web of Science ®Google Scholar
• Szczepanski J, Spencer SK, Griffin A, Bowles T, Williams JM, Kyle PB, Dumas JP, Araji S, Wallace K . Acute kidney injury during pregnancy leads to increased sFlt-1 and sEng and decreased renal T regulatory cells in pregnant rats with HELLP syndrome. Biol Sex Differ. 2020;11(1):54. doi:10.1186/s13293-020-00331-6.
   PubMed Web of Science ®Google Scholar
• Droge LA, Perschel FH, Stutz N, Gafron A, Frank L, Busjahn A, Henrich W, Verlohren S . Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (Soluble fms-like tyrosine kinase 1)/PlGF (Placental Growth Factor)-Ratio in the clinical routine: a real-world study. Hypertension. 2021;77(2):461–71. doi:10.1161/HYPERTENSIONAHA.120.15146.
   PubMed Web of Science ®Google Scholar
• Hernandez I, Chissey A, Guibourdenche J, Atasoy R, Coumoul X, Fournier T, Beaudeux JL, Zerrad-Saadi A . Human placental NADPH oxidase mediates sFlt-1 and PlGF secretion in early pregnancy: exploration of the TGF-beta1/p38 MAPK pathways. Antioxidants (Basel). 2021;10:2.
   Google Scholar
• Li Y, Sun L, Zheng X, Liu J, Zheng R, Lv Y, . The clinical value of platelet parameters combined with sFlt-1/PlGF in predicting preeclampsia. Ann Palliat Med. 2021;10(7):7619–26. doi:10.21037/apm-21-1244.
   PubMed Web of Science ®Google Scholar
• Bidarimath M, Khalaj K, Wessels JM, Tayade C. MicroRNAs, immune cells and pregnancy. Cell Mol Immunol. 2014;11(6):538–47. doi:10.1038/cmi.2014.45.
   PubMed Web of Science ®Google Scholar
• Thyagarajan A, Shaban A, Sahu RP. MicroRNA-directed cancer therapies: implications in melanoma intervention. J Pharmacol Exp Ther. 2018;364(1):1–12. doi:10.1124/jpet.117.242636.
   PubMed Web of Science ®Google Scholar
• Jin Y, Jia T, Wu X, Wang Y, Sun W, Chen Y, Wu G . The predictive value of microRNA in early hypertensive disorder complicating pregnancy (HDCP). Am J Transl Res. 2021;13:7288–93.
   PubMed Web of Science ®Google Scholar
• Li J, Wu Y, Liu H. Expression and role of miR-338-3p in peripheral blood and placenta of patients with pregnancy-induced hypertension. Exp Ther Med. 2020;20(1):418–26. doi:10.3892/etm.2020.8719.
   PubMed Web of Science ®Google Scholar
• Ou M, Zhao H, Ji G, Zhao X, Zhang Q. Long noncoding RNA MALAT1 contributes to pregnancy-induced hypertension development by enhancing oxidative stress and inflammation through the regulation of the miR-150-5p/ET-1 axis. FASEB J. 2020;34(5):6070–85. doi:10.1096/fj.201902280R.
   PubMed Web of Science ®Google Scholar
• Liu DF, Li SM, Zhu QX, Jiang W. The involvement of miR-155 in blood pressure regulation in pregnant hypertension rat via targeting FOXO3a. Eur Rev Med Pharmacol Sci. 2018;22(20):6591–98. doi:10.26355/eurrev_201810_16133.
   PubMed Web of Science ®Google Scholar
• Huang J, Zheng L, Kong H, Wang F, Su Y, Xin H . miR-139-5p promotes the proliferation and invasion of trophoblast cells by targeting sFlt-1 in preeclampsia. Placenta. 2020;92:37–43.
   PubMed Web of Science ®Google Scholar
• Sandrim VC, Eleuterio N, Pilan E, Tanus-Santos JE, Fernandes K, Cavalli R . Plasma levels of increased miR-195-5p correlates with the sFLT-1 levels in preeclampsia. Hypertens Pregnancy. 2016;35(2):150–58. doi:10.3109/10641955.2015.1122034.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang Y, Li J, Zhong Q, Li Y. MiR-101 inhibits migration and invasion of trophoblast HTR-8/SVneo cells by targeting CXCL6 in preeclampsia. Minerva Med. 2021;112(2):302–03. doi:10.23736/S0026-4806.19.06225-6.
   PubMed Web of Science ®Google Scholar
• Cui J, Chen X, Lin S, Li L, Fan J, Hou H, Li P . MiR-101-containing extracellular vesicles bind to BRD4 and enhance proliferation and migration of trophoblasts in preeclampsia. Stem Cell Res Ther. 2020;11(1):231. doi:10.1186/s13287-020-01720-9.
   PubMed Web of Science ®Google Scholar
• Zou Y, Jiang Z, Yu X, Zhang Y, Sun M, Wang W, Ge Z, De W, Sun L . MiR-101 regulates apoptosis of trophoblast HTR-8/SVneo cells by targeting endoplasmic reticulum (ER) protein 44 during preeclampsia. J Hum Hypertens. 2014;28(10):610–16. doi:10.1038/jhh.2014.35.
   PubMed Web of Science ®Google Scholar
• Akgor U, Ayaz L, Cayan F. Expression levels of maternal plasma microRNAs in preeclamptic pregnancies. J Obstet Gynaecol. 2021;41(6):910–14. doi:10.1080/01443615.2020.1820465.
   PubMedGoogle Scholar
• Barakat R, Pelaez M, Cordero Y, Perales M, Lopez C, Coteron J, Mottola MF . Exercise during pregnancy protects against hypertension and macrosomia: randomized clinical trial. Am J Obstet Gynecol. 2016;214(5):649 e641–648. doi:10.1016/j.ajog.2015.11.039.
   Web of Science ®Google Scholar
• Liu FM, Zhao M, Wang M, Yang HL, Li L. Effect of regular oral intake of aspirin during pregnancy on pregnancy outcome of high-risk pregnancy-induced hypertension syndrome patients. Eur Rev Med Pharmacol Sci. 2016;20(23):5013–16.
   PubMed Web of Science ®Google Scholar
• Johnson P, Montgomery M, Ewell P. Elevated blood pressure in low-income, rural preschool children is associated with maternal hypertension during pregnancy. J Community Health Nurs. 2018;35(1):12–18. doi:10.1080/07370016.2018.1404830.
   PubMed Web of Science ®Google Scholar
• Madsen C, Haberg SE, Aamodt G, Stigum H, Magnus P, London SJ, Nystad W, Nafstad P . Preeclampsia and hypertension during pregnancy in areas with relatively low levels of traffic air pollution. Matern Child Health J. 2018;22(4):512–19. doi:10.1007/s10995-017-2417-6.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1.
   PubMed Web of Science ®Google Scholar
• He X, Ding D. High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes. BMC Pregnancy Childbirth. 2022;22(1):490. doi:10.1186/s12884-022-04785-x.
   PubMed Web of Science ®Google Scholar
• Akehurst C, Small HY, Sharafetdinova L, Forrest R, Beattie W, Brown CE, Robinson SW, McClure JD, Work LM, Carty DM, et al. Differential expression of microRNA-206 and its target genes in preeclampsia. J Hypertens. 2015;33(10):2068–74. doi:10.1097/HJH.0000000000000656.
   PubMed Web of Science ®Google Scholar
• Jaafar J, Pechere-Bertschi A, Ditisheim A. Hypertension in pregnancy: practical considerations. Rev Med Suisse. 2014;10(441):1645–49.
   PubMedGoogle Scholar
• Jayaballa M, Sood S, Alahakoon I, Padmanabhan S, Cheung NW, Lee V . Microalbuminuria is a predictor of adverse pregnancy outcomes including preeclampsia. Pregnancy Hypertens. 2015;5(4):303–07. doi:10.1016/j.preghy.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Lei T, Qiu T, Liao W, Li K, Lai X, Huang H, Yuan R, Chen L . Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study. Reprod Biol Endocrinol. 2021;19(1):71. doi:10.1186/s12958-021-00751-y.
   PubMed Web of Science ®Google Scholar
• Kasraeian M, Asadi N, Vafaei H, Zamanpour T, Raeisi-Shahraki H, Bazrafshan K . Evaluation of serum biomarkers for detection of preeclampsia severity in pregnant women. Pak J Med Sci. 2018;34(4):869–73. doi:10.12669/pjms.344.14393.
   PubMed Web of Science ®Google Scholar
• Kong D, Wang H, Liu Y, Li H, Wang H, Zhu P . Correlation between the expression of inflammatory cytokines IL-6, TNF-alpha and hs-CRP and unfavorable fetal outcomes in patients with pregnancy-induced hypertension. Exp Ther Med. 2018;16(3):1982–86. doi:10.3892/etm.2018.6393.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lechuga B, Lara-Barea A, Cordoba-Dona JA, Montero Galvan A, Abal Cruz A, Aguilar-Diosdado M, Lopez-Tinoco C . Usefulness of blood pressure monitoring in patients with gestational diabetes mellitus. Endocrinol Diabetes Nutr (Engl Ed). 2018;65(7):394–401. doi:10.1016/j.endinu.2018.02.005.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang B, Wang HY, Chang A, Zheng XFS. Emerging role of microRNAs in mTOR signaling. Cell Mol Life Sci. 2017;74(14):2613–25. doi:10.1007/s00018-017-2485-1.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Miura K, Sato S, Higashijima A, Hasegawa Y, Miura S, Yoshiura K-I, Masuzaki H . Reference values for circulating pregnancy-associated microRNAs in maternal plasma and their clinical usefulness in uncomplicated pregnancy and hypertensive disorder of pregnancy. J Obstet Gynaecol Res. 2018;44(5):840–51. doi:10.1111/jog.13610.
   PubMed Web of Science ®Google Scholar
• Moore KH, Chapman H, George EM. Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix. Biol Sex Differ. 2020;11(1):34. doi:10.1186/s13293-020-00311-w.
   PubMed Web of Science ®Google Scholar
• Matin M, Morgelin M, Stetefeld J, Schermer B, Brinkkoetter PT, Benzing T, Koch M, Hagmann H . Affinity-enhanced multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) variants for specific adsorption of sFlt-1 to restore angiogenic balance in preeclampsia. Hypertension. 2020;76(4):1176–84. doi:10.1161/HYPERTENSIONAHA.120.14974.
   PubMed Web of Science ®Google Scholar
• Hernandez-Pacheco JA, Torres-Torres J, Martinez-Portilla RJ, Solis-Paredes JM, Estrada-Gutierrez G, Mateu-Rogell P, Nares-Torices MA, Lopez-Marenco ME, Escobedo-Segura KR, Posadas-Nava A, Villafan-Bernal JR, Rojas-Zepeda L, Becerra-Navarro NP, Casillas-Barrera M, Pichardo-Cuevas M, Munoz-Manrique C, Cortes-Ramirez IA, Espino YSS . sFlt-1 is an independent predictor of adverse maternal outcomes in women with SARS-CoV-2 infection and hypertensive disorders of pregnancy. Front Med (Lausanne). 2022;9:894633.
   PubMed Web of Science ®Google Scholar
• Szczerba E, Zajkowska A, Bochowicz A, Pankiewicz K, Szewczyk G, Opolski G, Maciejewski T, Malecki M, Fijalkowska A . Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function. Biomed Rep. 2020;13(5):41. doi:10.3892/br.2020.1348.
   PubMed Web of Science ®Google Scholar
• Valenzuela-Melgarejo FJ, Lagunas C, Carmona-Pasten F, Jara-Medina K, Delgado G. Supraphysiological role of melatonin over vascular dysfunction of pregnancy, a new therapeutic agent? Front Physiol. 2021;12:767684. doi:10.3389/fphys.2021.767684.
   PubMed Web of Science ®Google Scholar
• Hu TX, Guo X, Wang G, Gao L, He P, Xia Y, Gu H, Ni X . MiR133b is involved in endogenous hydrogen sulfide suppression of sFlt-1 production in human placenta. Placenta. 2017;52:33–40.
   PubMed Web of Science ®Google Scholar
• Dai S, Zhu X, Xia H. MiR-2467 is a potential marker for prediction of gestational diabetes mellitus in pregnancy. Clin Lab. 2020;66(10/2020):10. doi:10.7754/Clin.Lab.2020.200233.
   Web of Science ®Google Scholar
• Li T, Zhou B, He Y, Liu J, Li Y. Expression and clinical diagnostic value of miR-383 in patients with severe preeclampsia. Cell Mol Biol (Noisy-le-grand). 2020;66(3):92–100. doi:10.14715/cmb/2020.66.3.14.
   PubMed Web of Science ®Google Scholar